Filing Details

Accession Number:
0001209191-16-126674
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-08 20:34:17
Reporting Period:
2016-06-07
Filing Date:
2016-06-08
Accepted Time:
2016-06-08 20:34:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1592288 Dimension Therapeutics Inc. DMTX Biological Products, (No Disgnostic Substances) (2836) 463942159
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1653061 Reed K. Clark C/O Dimension Therapeutics, Inc.
840 Memorial Drive, 4Th Floor
Cambridge MA 02139
Svp Of Pharmaceutical Develop No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-06-07 5,000 $0.38 5,000 No 4 M Direct
Common Stock Disposition 2016-06-07 5,000 $10.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2016-06-07 5,000 $0.00 5,000 $0.38
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
114,739 2024-04-21 No 4 M Direct
Footnotes
  1. This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  3. This stock option vests over four (4) years beginning on April 1, 2014, at a rate of twenty-five percent (25%) after 12 months, and in thirty-six (36) equal monthly installments thereafter.